Homocystinuria Clinical Trial
Official title:
Effects of Exercise on Metabolic Parameters in Treated Patients With Classical Homocystinuria: a Research Project on a Small Sample Size, Compared to Healthy Controls.
The aim of this research project is to compare the effect of an aerobic exercise session in two different populations. Sampling biological material and collecting health-related personal data entails minimal risks and burdens. Participants will be asked to perform 30 minutes of an aerobic exercise on an ergocycle at a fixed power output to correspond to a moderate intensity for a sedentary population.
Background Among genetic causes of hyperhomocysteinemia, classical homocystinuria, manifest not only with vascular diseases but also with neurological symptoms. This is related to the higher homocysteine concentration of up to 150-300 μmol/l without treatment. Recently, some articles have shown that mild and temporary hyperhomocysteinemia may follow exercise in a healthy population. Investigators hypothesized that increase in homocysteine may be of greater importance in patients with classical homocystinuria where cystathionine beta-synthase deficiency prevents homocysteine metabolism. Objective To investigate the effect of an aerobic exercise in patients with classical homocystinuria on metabolic parameters compared to healthy controls. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05687474 -
Baby Detect : Genomic Newborn Screening
|
||
| Recruiting |
NCT05910151 -
Selective Screening of Children for Hereditary Metabolic Diseases by Tandem Mass Spectrometry in Kazakhstan
|
||
| Enrolling by invitation |
NCT03655223 -
Early Check: Expanded Screening in Newborns
|
||
| Completed |
NCT00483314 -
Homocystinuria: Treatment With N-Acetylcysteine
|
Phase 2 | |
| Recruiting |
NCT05051657 -
Evaluation of the Express Plus Range
|
N/A | |
| Completed |
NCT05462132 -
Safety, Tolerability and Pharmacodynamics of SYNB1353 in Healthy Adult Volunteers
|
Phase 1 | |
| Completed |
NCT02404337 -
Betaine METABOLISM OF PATIENTS With Homocystinuria
|
Phase 2 | |
| Active, not recruiting |
NCT03406611 -
Pegtibatinase as an Enzyme Therapy for Patients With Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency (COMPOSE)
|
Phase 1/Phase 2 | |
| Completed |
NCT01192828 -
Oxidative Stress Markers In Inherited Homocystinuria And The Impact Of Taurine
|
Phase 1/Phase 2 | |
| Completed |
NCT00004356 -
Study of Homocysteine Metabolism in Homocystinuria
|
N/A | |
| Recruiting |
NCT06247085 -
A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Age With Classical Homocystinuria (HCU) Due to Cystathionine Beta Synthase Deficiency Receiving Standard of Care Treatment
|
Phase 3 | |
| Enrolling by invitation |
NCT06431893 -
A Phase 3 Long-term Extension Study to Assess the Long-term Safety and Efficacy of Pegtibatinase Treatment in Participants ≥12 to ≤65 Years of Age With Classical Homocystinuria (HCU)
|
Phase 3 |